Practical approaches to management of hyperphosphatemia: Can we improve the current situation?

Blood Purification

Volumn 25, Issue 1, 2006, Pages 120-124

  Kuhlmann, Martin K ^a  

^a VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

Author keywords

Hemodiafiltration; Hyperphosphatemia, management; Phosphorus balance

Indexed keywords

CALCIUM ACETATE; PHOSPHATE BINDING AGENT; SEVELAMER;

CONFERENCE PAPER; DIET RESTRICTION; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; PRIORITY JOURNAL;

HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; PATIENT EDUCATION; PHOSPHATES; PHOSPHORUS; PHOSPHORUS METABOLISM DISORDERS; PHOSPHORUS, DIETARY; SELF CARE;

EID: 33845739746     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096410     Document Type: Conference Paper

References (24)

1. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
2. Melamed ML, Eutace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR: Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 2006;70:351-357.
3. Block GA, Port FK: Re-evaluation of risk associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000;35:1226-1237.
4. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(suppl 3):S1-S202.
5. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44(suppl 2):34-38.
6. DeSoi CA, Umans JG: Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol 1993;4:1214-1218.
7. Gotch FA, Panlilio F, Sergeyeva O, et al: A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 2003;21:51-57.
8. Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002;61:655-667.
9. Gotch FA, Panlilio F, Sergeyeva O, Rosales L, Folden T, Kaysen G, Levin NW: Effective diffusion volume flow rates (Qe) for urea, creatinine, and inorganic phosphorous (Qeu, Qecr, QeiP) during hemodialysis. Semin Dial 2003;16:474-476.
10. Mandolfo S, Malberti F, Imbasciati E, Cogliati P, Gauly A: Impact of blood and dialysate flow and surface on performance of new polysulfone hemodialysis dialyzers. Int J Artif Organs 2003;26:113-120.
11. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Garbani E, Zehnder CE: Increasing blood flow increases Kt/V(urea) and potassium removal but fails to improve phosphate removal. Clin Nephrol 2003;59:130-136.
12. Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG: Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis 2004;43:85-89.
13. Minutolo R, Bellizzi V, Cioffi M, et al: Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. J Am Soc Nephrol 2002;13:1046-1054.
14. Zehnder C, Gutzwiller JP, Renggli K: Hemodiafiltration - a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 1999;52:152-159.
15. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, Uldall R: Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998;9:859-868.
16. Mucsi I, Hercz G, Uldall R, et al: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998;53:1399-1404.
17. Ayus JC, Mizani M, Achinger SG, Thadhani R, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective controlled study. J Am Soc Nephrol 2005;16:2778-2788.
18. Lindsay RM, Alhejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim AP, Kortas C: Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003;42(1 suppl):24-29.
19. Yuen D, Richardson RM, Chan CT: Improvements in phosphate control with short daily in-center hemodialysis. Clin Nephrol 2005;64:364-370.
20. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA: Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 2003;64:305-313.
21. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G: Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 2002;12:17-31.
22. Murphy-Gutekunst L: Hidden phosphorous in popular beverages. J Ren Nutr 2005;15:e1-e6.
23. Uribarri J, Calvo MS: Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial 2003;16:186-188.
24. Chertow GM, Burke SK, Raggi P; Treat to Goal Working Group: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.